What’s on the Horizon for Multiple Myeloma Treatment?

By Cecilia Brown, Elizabeth Finley-Oliver, MSN, ARNP, AGNP-BC, Rachid Baz, MD - Last Updated: November 13, 2023

Rachid Baz, MD, and Elizabeth Finley-Oliver, MSN, ARNP, AGNP-BC, of the Moffitt Cancer Center, delivered a presentation titled “Individualizing Care for Multiple Myeloma: Navigating Treatment Options and Addressing Patient Needs” at JADPRO Live 2023, the Annual APSHO Meeting.

Dr. Baz and Ms. Finley-Oliver discussed what they see on the horizon for multiple myeloma treatment, as well as what they hope attendees learned from the presentation.

“There are new classes of drugs, new targeted therapies that are available… hopefully there is enough there to pique their interest to want to read more, educate themselves more,” Dr. Baz said.

Ms. Finley-Oliver said she hoped those who attended the presentation learned about supportive care for patients with multiple myeloma receiving novel therapies. She also hopes attendees learned about where treatment for multiple myeloma is headed. “In oncology, we always think about the next step… so it’s kind of exciting to see there are lots of options now for patients and they’re living longer,” she said.

Dr. Baz and Ms. Finley-Oliver spoke about what they hope to see happen in multiple myeloma treatment and research. Dr. Baz said the disease can be a chronic illness for some patients now, but the goal is to “reach functional cures” for more patients. With multiple myeloma being a chronic condition for more patients, Ms. Finley-Oliver emphasized that “quality of life is important” and that “there’s a lot of room to be optimistic.”

Post Tags:JADPRO 2023 MM